{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:16:57Z","timestamp":1785421017180,"version":"3.56.0"},"reference-count":54,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Saudi Arabia Cultural Mission","award":["1080231549"],"award-info":[{"award-number":["1080231549"]}]},{"DOI":"10.13039\/100006952","name":"Louisiana Board of Regents","doi-asserted-by":"crossref","award":["LEQSF-2023-24-ENH-DE-26"],"award-info":[{"award-number":["LEQSF-2023-24-ENH-DE-26"]}],"id":[{"id":"10.13039\/100006952","id-type":"DOI","asserted-by":"crossref"}]},{"award":["LEQSF-2023-24-ENH-DE-26"],"award-info":[{"award-number":["LEQSF-2023-24-ENH-DE-26"]}],"id":[{"id":"https:\/\/ror.org\/00jv89z46","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Prostate cancer (PCa) is among the highest incidence malignancies in men, with high rates of inevitable resistance development, relapse, and mortality. Castration-resistant prostate cancer (CRPC) continued to pose substantial therapeutic challenges, highlighting the urgent need for effective treatment options. This study assessed the marine cembranoid sarcophine activity against the progression and recurrence of the metastatic CRPC (mCRPC) in mouse xenograft models. Protein and phosphorylation levels were assessed by immunoblotting and mRNA expression by qPCR and RNA sequencing. The in vivo efficacy was evaluated through tumor progression over 3 weeks followed by primary tumor excision and recurrence monitoring over an 8-week course. Sarcophine significantly reduced the mCRPC CWR-R1ca tumor volume by 74.1% and suppressed the epigenetic regulators EZH2 and SMYD2; lineage plasticity factors ASCL1 and BRN2; Wnt\/stemness signaling markers \u03b2-catenin and LGR6; AKT total expression and activation; and invasion-associated proteins TRPC4 and MMP2 in primary tumors. Sarcophine effectively prevented the mCRPC locoregional recurrence, as well as lung and spleen distant recurrences, and effectively reduced recurrence in other organs. Transcriptomics-RNA-Seq analysis of primary tumors identified 2697 downregulated and 3534 upregulated genes, indicating broad transcriptional reprogramming following sarcophine treatments. These findings demonstrate coordinated suppression of multi-oncogenic pathways and validate the therapeutic potential of sarcophine to control mCRPC.<\/jats:p>","DOI":"10.3390\/md24070223","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:11:49Z","timestamp":1782234709000},"page":"223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Marine Cembranoid Sarcophine Suppressed the Progression and Recurrence of the Metastatic Castration-Resistant Prostate Cancer via Downregulating EZH2-\u03b2-Catenin-Centered Oncogenic Network"],"prefix":"10.3390","volume":"24","author":[{"given":"Abdullah T.","family":"Alhowiriny","sequence":"first","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-4582","authenticated-orcid":false,"given":"Hassan Y.","family":"Ebrahim","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA"},{"name":"Department of Biomedical Sciences, Discipline of Pharmacology, Edward Via College of Osteopathic Medicine, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethar A.","family":"Mudhish","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"Dawud","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA"},{"name":"Department of Biomedical Sciences, Discipline of Pharmacology, Edward Via College of Osteopathic Medicine, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-4064","authenticated-orcid":false,"given":"Khalid A.","family":"El Sayed","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"GBD 2023 Cancer Collaborators (2025). The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: A systematic analysis for the global burden of disease study 2023. Lancet, 406, 1565\u20131586.","DOI":"10.2139\/ssrn.5533924"},{"key":"ref_2","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"e76224","article-title":"Therapeutic challenges in metastatic castration-resistant prostate cancer: A case study and review of prostate-specific membrane antigen-targeted therapy failures in highly prostate-specific membrane antigen-avid disease","volume":"16","author":"Moghrabi","year":"2024","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"CMO-Ss34534","DOI":"10.4137\/CMO.Ss34534","article-title":"Resistance to novel antiandrogen therapies in metastatic castration-resistant prostate cancer","volume":"10","author":"Boudadi","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Le, T.K., Duong, Q.H., Baylot, V., Fargette, C., Baboudjian, M., Colleaux, L., Ta\u00efeb, D., and Rocchi, P. (2023). Castration-resistant prostate cancer: From uncovered resistance mechanisms to current treatments. Cancers, 15.","DOI":"10.3390\/cancers15205047"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","article-title":"The master neural transcription factor BRN2 is an androgen receptor-suppressed driver of neuroendocrine differentiation in prostate cancer","volume":"7","author":"Bishop","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13659-024-00493-5","article-title":"Marine natural products as a source of novel anticancer drugs: An updated review (2019-2023)","volume":"15","author":"Refaey","year":"2025","journal-title":"Nat. Prod. Bioprospect."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Montuori, E., Hyde, C.A.C., Crea, F., Golding, J., and Lauritano, C. (2023). Marine natural products with activities against prostate cancer: Recent discoveries. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021435"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1039\/D5NP00080G","article-title":"Marine natural products","volume":"43","author":"Carroll","year":"2026","journal-title":"Nat. Prod. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shorning, B.Y., Dass, M.S., Smalley, M.J., and Pearson, H.B. (2020). The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124507"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/ERC-12-0394","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer","volume":"20","author":"Bitting","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12079-022-00702-1","article-title":"Targeting PI3K\/Akt signaling in prostate cancer therapy","volume":"17","author":"Hashemi","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12672-021-00433-6","article-title":"Wnt\/\u03b2-catenin signal transduction pathway in prostate cancer and associated drug resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Discov. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/\u03b2-catenin mediated signaling pathways in cancer: Recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.aab0917","article-title":"RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance","volume":"349","author":"Miyamoto","year":"2015","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Koushyar, S., Meniel, V.S., Phesse, T.J., and Pearson, H.B. (2022). Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12020309"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1038\/s41388-021-01982-4","article-title":"Going beyond Polycomb: EZH2 functions in prostate cancer","volume":"40","author":"Park","year":"2021","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","article-title":"N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer","volume":"30","author":"Dardenne","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_20","first-page":"749","article-title":"The many faces of EZH2: A histone methyltransferase in cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2019.10.004","article-title":"Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis","volume":"29","author":"Zeng","year":"2019","journal-title":"Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s12276-024-01326-8","article-title":"SMYD family in cancer: Epigenetic regulation and molecular mechanisms of cancer proliferation, metastasis, and drug resistance","volume":"56","author":"Han","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","article-title":"Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1","volume":"84","author":"Rodarte","year":"2024","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Maylin, Z.R., Smith, C., Classen, A., Asim, M., Pandha, H., and Wang, Y. (2024). Therapeutic exploitation of neuroendocrine transdifferentiation drivers in prostate cancer. Cells, 13.","DOI":"10.3390\/cells13231999"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ardura, J.A., \u00c1lvarez-Carri\u00f3n, L., Guti\u00e9rrez-Rojas, I., and Alonso, V. (2020). Role of calcium signaling in prostate cancer progression: Effects on cancer hallmarks and bone metastatic mechanisms. Cancers, 12.","DOI":"10.3390\/cancers12051071"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Negri, S., Faris, P., Berra-Romani, R., Guerra, G., and Moccia, F. (2020). Endothelial transient receptor potential channels and vascular remodeling: Extracellular Ca2+ entry for angiogenesis, arteriogenesis and vasculogenesis. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01618"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/cancers6031298","article-title":"Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression","volume":"6","author":"Gong","year":"2014","journal-title":"Cancers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0041-0101(74)90192-5","article-title":"Sarcophine\u2014A new toxin from the soft coral Sarcophyton glaucum (Alcyonaria)","volume":"12","author":"Fishelson","year":"1974","journal-title":"Toxicon"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1248\/cpb.54.1119","article-title":"Anticancer and Anti-inflammatory Sulfur-Containing Semisynthetic Derivatives of Sarcophine","volume":"54","author":"Sawant","year":"2006","journal-title":"Chem. Pharm. Bull."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Elkhawas, Y.A., Elissawy, A.M., Elnaggar, M.S., Mostafa, N.M., and El-Khatib, A.H. (2020). Chemical Diversity in Species Belonging to Soft Coral Genus Sacrophyton and Its Impact on Biological Activity: A Review. Mar. Drugs, 18.","DOI":"10.3390\/md18010041"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/md10010209","article-title":"Bioactive hydroperoxyl cembranoids from the Red Sea soft coral Sarcophyton glaucum","volume":"10","author":"Hegazy","year":"2012","journal-title":"Mar. Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md10010001","article-title":"Sarcophine-diol, a skin cancer chemopreventive agent, inhibits proliferation and stimulates apoptosis in mouse melanoma B16F10 cell line","volume":"10","author":"Szymanski","year":"2011","journal-title":"Mar. Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.bmc.2011.06.060","article-title":"Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors","volume":"19","author":"Hassan","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Siddique, A.B., King, J.A., Meyer, S.A., Abdelwahed, K., Busnena, B., and El Sayed, K. (2020). Safety evaluations of single dose of the olive secoiridoid S-(-)-oleocanthal in Swiss albino mice. Nutrients, 12.","DOI":"10.3390\/nu12020314"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.eururo.2025.06.013","article-title":"Novel therapeutic strategies for metastatic prostate cancer care","volume":"88","author":"Cimadamore","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s44446-025-00056-w","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in prostate cancer: Molecular dysregulation, therapeutic advances, and future directions","volume":"34","author":"Alobid","year":"2026","journal-title":"Saudi Pharm. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1021\/jo9813134","article-title":"Structurally Novel Bioconversion Products of the Marine Natural Product Sarcophine Effectively Inhibit JB6 Cell Transformation","volume":"63","author":"Hamann","year":"1998","journal-title":"J. Org. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1541-7786.MCR-24-0395","article-title":"Characterization of Wnt signaling pathway aberrations in metastatic prostate cancer","volume":"22","author":"Choi","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1038\/s41388-025-03631-6","article-title":"Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2474175","DOI":"10.1080\/07853890.2025.2474175","article-title":"Signalling pathways in a nutshell: From pathogenesis to therapeutical implications in prostate cancer","volume":"57","author":"Goncharov","year":"2025","journal-title":"Ann. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"bqad023","DOI":"10.1210\/endocr\/bqad023","article-title":"Beyond expression: Role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer","volume":"164","author":"Nouruzi","year":"2023","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOU.0000000000001015","article-title":"Genetics of neuroendocrine prostate cancer: Recent progress in genetic understanding is translating into therapeutic opportunities","volume":"32","author":"Williams","year":"2022","journal-title":"Curr. Opin. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Siddique, A., Ebrahim, H.Y., Tajmim, A., King, J., Abdelwahed, K., Abd Elmageed, Z.Y., and El Sayed, K.A. (2022). Oleocanthal attenuates metastatic castration-resistant prostate cancer progression and recurrence by targeting SMYD2. Cancers, 14.","DOI":"10.3390\/cancers14143542"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"ref_48","unstructured":"FastQC (2026, February 20). A Quality Control Tool for High Throughput Sequence Data. Available online: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Hurst","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.toxicon.2025.108628","article-title":"Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing","volume":"268","author":"Marriott","year":"2025","journal-title":"Toxicon"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/24\/7\/223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:16:55Z","timestamp":1782533815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/24\/7\/223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["md24070223"],"URL":"https:\/\/doi.org\/10.3390\/md24070223","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}